カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

凝固因子の世界市場2025年：凝固因子VIIa、凝固因子VIII、凝固因子IX、凝固因子X、その他

■ 英語タイトル：Global Coagulation Factors Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3777）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3777
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[凝固因子の世界市場2025年：凝固因子VIIa、凝固因子VIII、凝固因子IX、凝固因子X、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の凝固因子市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の凝固因子の市場規模は2024年のxxx米ドルから2031年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

凝固因子市場はタイプとアプリケーションによって区分されます。2020年～2031年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・凝固因子VIIa、凝固因子VIII、凝固因子IX、凝固因子X、その他

アプリケーション別セグメントは次のように区分されます。
・薬局、病院

世界の凝固因子市場の主要な市場プレーヤーは以下のとおりです。
・Takeda、Bayer、CSL、Pfizer、Grifols、Biogen、Octapharma、NovoNordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、凝固因子製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な凝固因子メーカーの企業概要、2022年～2024年までの凝固因子の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な凝固因子メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2020年～2031年までの地域別凝固因子の販売量、売上、成長性を示しています。
・第5、6章では、2020年～2031年までの凝固因子の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2020年～2024年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での凝固因子市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および凝固因子の産業チェーンを掲載しています。
・第13、14、15章では、凝固因子の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 凝固因子の概要
– 種類別分析（2020年vs2024年vs2031年）：凝固因子VIIa、凝固因子VIII、凝固因子IX、凝固因子X、その他
– 用途別分析（2020年vs2024年vs2031年）：薬局、病院
– 世界の凝固因子市場規模・予測
– 世界の凝固因子生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Takeda、Bayer、CSL、Pfizer、Grifols、Biogen、Octapharma、NovoNordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS
・メーカー別市場シェア・市場集中度
・地域別市場分析2020年-2031年
・種類別分析2020年-2031年：凝固因子VIIa、凝固因子VIII、凝固因子IX、凝固因子X、その他
・用途別分析2020年-2031年：薬局、病院
・凝固因子の北米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・凝固因子のヨーロッパ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・凝固因子のアジア市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・凝固因子の南米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・凝固因子の中東・アフリカ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Coagulation Factors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Coagulation Factors Revenue by Type: 2020 Versus 2024 Versus 2031
1.2.2 Coagulation Factor VIIa
1.2.3 Coagulation Factor VIII
1.2.4 Coagulation Factor IX
1.2.5 Coagulation Factor X
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Coagulation Factors Revenue by Application: 2020 Versus 2024 Versus 2031
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Global Coagulation Factors Market Size & Forecast
1.4.1 Global Coagulation Factors Sales in Value (2020 & 2024 & 2031)
1.4.2 Global Coagulation Factors Sales in Volume (2020-2031)
1.4.3 Global Coagulation Factors Price (2020-2031)
1.5 Global Coagulation Factors Production Capacity Analysis
1.5.1 Global Coagulation Factors Total Production Capacity (2020-2031)
1.5.2 Global Coagulation Factors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Coagulation Factors Market Drivers
1.6.2 Coagulation Factors Market Restraints
1.6.3 Coagulation Factors Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Coagulation Factors Product and Services
2.1.4 Takeda Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Coagulation Factors Product and Services
2.2.4 Bayer Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Coagulation Factors Product and Services
2.3.4 CSL Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Coagulation Factors Product and Services
2.4.4 Pfizer Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Coagulation Factors Product and Services
2.5.4 Grifols Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.6 Biogen
2.6.1 Biogen Details
2.6.2 Biogen Major Business
2.6.3 Biogen Coagulation Factors Product and Services
2.6.4 Biogen Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.7 Octapharma
2.7.1 Octapharma Details
2.7.2 Octapharma Major Business
2.7.3 Octapharma Coagulation Factors Product and Services
2.7.4 Octapharma Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.8 NovoNordisk
2.8.1 NovoNordisk Details
2.8.2 NovoNordisk Major Business
2.8.3 NovoNordisk Coagulation Factors Product and Services
2.8.4 NovoNordisk Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.9 Greencross
2.9.1 Greencross Details
2.9.2 Greencross Major Business
2.9.3 Greencross Coagulation Factors Product and Services
2.9.4 Greencross Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.10 Kedrion
2.10.1 Kedrion Details
2.10.2 Kedrion Major Business
2.10.3 Kedrion Coagulation Factors Product and Services
2.10.4 Kedrion Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.11 BPL
2.11.1 BPL Details
2.11.2 BPL Major Business
2.11.3 BPL Coagulation Factors Product and Services
2.11.4 BPL Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.12 Hualan Bio
2.12.1 Hualan Bio Details
2.12.2 Hualan Bio Major Business
2.12.3 Hualan Bio Coagulation Factors Product and Services
2.12.4 Hualan Bio Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.13 RAAS
2.13.1 RAAS Details
2.13.2 RAAS Major Business
2.13.3 RAAS Coagulation Factors Product and Services
2.13.4 RAAS Coagulation Factors Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
3 Coagulation Factors Breakdown Data by Manufacturer
3.1 Global Coagulation Factors Sales in Volume by Manufacturer (2021, 2022, 2023, and 2024)
3.2 Global Coagulation Factors Revenue by Manufacturer (2021, 2022, 2023, and 2024)
3.3 Key Manufacturer Market Position in Coagulation Factors
3.4 Market Concentration Rate
3.4.1 Top 3 Coagulation Factors Manufacturer Market Share in 2024
3.4.2 Top 6 Coagulation Factors Manufacturer Market Share in 2024
3.5 Global Coagulation Factors Production Capacity by Company: 2023 VS 2024
3.6 Manufacturer by Geography: Head Office and Coagulation Factors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Coagulation Factors Market Size by Region
4.1.1 Global Coagulation Factors Sales in Volume by Region (2020-2031)
4.1.2 Global Coagulation Factors Revenue by Region (2020-2031)
4.2 North America Coagulation Factors Revenue (2020-2031)
4.3 Europe Coagulation Factors Revenue (2020-2031)
4.4 Asia-Pacific Coagulation Factors Revenue (2020-2031)
4.5 South America Coagulation Factors Revenue (2020-2031)
4.6 Middle East and Africa Coagulation Factors Revenue (2020-2031)
5 Market Segment by Type
5.1 Global Coagulation Factors Sales in Volume by Type (2020-2031)
5.2 Global Coagulation Factors Revenue by Type (2020-2031)
5.3 Global Coagulation Factors Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Coagulation Factors Sales in Volume by Application (2020-2031)
6.2 Global Coagulation Factors Revenue by Application (2020-2031)
6.3 Global Coagulation Factors Price by Application (2020-2031)
7 North America by Country, by Type, and by Application
7.1 North America Coagulation Factors Sales by Type (2020-2031)
7.2 North America Coagulation Factors Sales by Application (2020-2031)
7.3 North America Coagulation Factors Market Size by Country
7.3.1 North America Coagulation Factors Sales in Volume by Country (2020-2031)
7.3.2 North America Coagulation Factors Revenue by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe by Country, by Type, and by Application
8.1 Europe Coagulation Factors Sales by Type (2020-2031)
8.2 Europe Coagulation Factors Sales by Application (2020-2031)
8.3 Europe Coagulation Factors Market Size by Country
8.3.1 Europe Coagulation Factors Sales in Volume by Country (2020-2031)
8.3.2 Europe Coagulation Factors Revenue by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Coagulation Factors Sales by Type (2020-2031)
9.2 Asia-Pacific Coagulation Factors Sales by Application (2020-2031)
9.3 Asia-Pacific Coagulation Factors Market Size by Region
9.3.1 Asia-Pacific Coagulation Factors Sales in Volume by Region (2020-2031)
9.3.2 Asia-Pacific Coagulation Factors Revenue by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America by Region, by Type, and by Application
10.1 South America Coagulation Factors Sales by Type (2020-2031)
10.2 South America Coagulation Factors Sales by Application (2020-2031)
10.3 South America Coagulation Factors Market Size by Country
10.3.1 South America Coagulation Factors Sales in Volume by Country (2020-2031)
10.3.2 South America Coagulation Factors Revenue by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Coagulation Factors Sales by Type (2020-2031)
11.2 Middle East & Africa Coagulation Factors Sales by Application (2020-2031)
11.3 Middle East & Africa Coagulation Factors Market Size by Country
11.3.1 Middle East & Africa Coagulation Factors Sales in Volume by Country (2020-2031)
11.3.2 Middle East & Africa Coagulation Factors Revenue by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Raw Material and Industry Chain
12.1 Raw Material of Coagulation Factors and Key Manufacturers
12.2 Manufacturing Costs Percentage of Coagulation Factors
12.3 Coagulation Factors Production Process
12.4 Coagulation Factors Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Coagulation Factors Typical Distributors
13.3 Coagulation Factors Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Coagulation Factors Revenue by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Coagulation Factors Revenue by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Coagulation Factors Product and Services
Table 6. Takeda Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Coagulation Factors Product and Services
Table 10. Bayer Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Coagulation Factors Product and Services
Table 14. CSL Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Coagulation Factors Product and Services
Table 18. Pfizer Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 19. Grifols Basic Information, Manufacturing Base and Competitors
Table 20. Grifols Major Business
Table 21. Grifols Coagulation Factors Product and Services
Table 22. Grifols Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 23. Biogen Basic Information, Manufacturing Base and Competitors
Table 24. Biogen Major Business
Table 25. Biogen Coagulation Factors Product and Services
Table 26. Biogen Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 27. Octapharma Basic Information, Manufacturing Base and Competitors
Table 28. Octapharma Major Business
Table 29. Octapharma Coagulation Factors Product and Services
Table 30. Octapharma Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 31. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 32. NovoNordisk Major Business
Table 33. NovoNordisk Coagulation Factors Product and Services
Table 34. NovoNordisk Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 35. Greencross Basic Information, Manufacturing Base and Competitors
Table 36. Greencross Major Business
Table 37. Greencross Coagulation Factors Product and Services
Table 38. Greencross Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 39. Kedrion Basic Information, Manufacturing Base and Competitors
Table 40. Kedrion Major Business
Table 41. Kedrion Coagulation Factors Product and Services
Table 42. Kedrion Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 43. BPL Basic Information, Manufacturing Base and Competitors
Table 44. BPL Major Business
Table 45. BPL Coagulation Factors Product and Services
Table 46. BPL Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 47. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 48. Hualan Bio Major Business
Table 49. Hualan Bio Coagulation Factors Product and Services
Table 50. Hualan Bio Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 51. RAAS Basic Information, Manufacturing Base and Competitors
Table 52. RAAS Major Business
Table 53. RAAS Coagulation Factors Product and Services
Table 54. RAAS Coagulation Factors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 55. Global Coagulation Factors Sales by Manufacturer (2021, 2022, 2023, and 2024) & (K Units)
Table 56. Global Coagulation Factors Revenue by Manufacturer (2021, 2022, 2023, and 2024) & (USD Million)
Table 57. Market Position of Manufacturers in Coagulation Factors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 58. Global Coagulation Factors Production Capacity by Company, (K Units): 2023 VS 2024
Table 59. Head Office and Coagulation Factors Production Site of Key Manufacturer
Table 60. Coagulation Factors New Entrant and Capacity Expansion Plans
Table 61. Coagulation Factors Mergers & Acquisitions in the Past Five Years
Table 62. Global Coagulation Factors Sales by Region (2020-2024) & (K Units)
Table 63. Global Coagulation Factors Sales by Region (2025-2031) & (K Units)
Table 64. Global Coagulation Factors Revenue by Region (2020-2024) & (USD Million)
Table 65. Global Coagulation Factors Revenue by Region (2025-2031) & (USD Million)
Table 66. Global Coagulation Factors Sales by Type (2020-2024) & (K Units)
Table 67. Global Coagulation Factors Sales by Type (2025-2031) & (K Units)
Table 68. Global Coagulation Factors Revenue by Type (2020-2024) & (USD Million)
Table 69. Global Coagulation Factors Revenue by Type (2025-2031) & (USD Million)
Table 70. Global Coagulation Factors Price by Type (2020-2024) & (USD/Unit)
Table 71. Global Coagulation Factors Price by Type (2025-2031) & (USD/Unit)
Table 72. Global Coagulation Factors Sales by Application (2020-2024) & (K Units)
Table 73. Global Coagulation Factors Sales by Application (2025-2031) & (K Units)
Table 74. Global Coagulation Factors Revenue by Application (2020-2024) & (USD Million)
Table 75. Global Coagulation Factors Revenue by Application (2025-2031) & (USD Million)
Table 76. Global Coagulation Factors Price by Application (2020-2024) & (USD/Unit)
Table 77. Global Coagulation Factors Price by Application (2025-2031) & (USD/Unit)
Table 78. North America Coagulation Factors Sales by Country (2020-2024) & (K Units)
Table 79. North America Coagulation Factors Sales by Country (2025-2031) & (K Units)
Table 80. North America Coagulation Factors Revenue by Country (2020-2024) & (USD Million)
Table 81. North America Coagulation Factors Revenue by Country (2025-2031) & (USD Million)
Table 82. North America Coagulation Factors Sales by Type (2020-2024) & (K Units)
Table 83. North America Coagulation Factors Sales by Type (2025-2031) & (K Units)
Table 84. North America Coagulation Factors Sales by Application (2020-2024) & (K Units)
Table 85. North America Coagulation Factors Sales by Application (2025-2031) & (K Units)
Table 86. Europe Coagulation Factors Sales by Country (2020-2024) & (K Units)
Table 87. Europe Coagulation Factors Sales by Country (2025-2031) & (K Units)
Table 88. Europe Coagulation Factors Revenue by Country (2020-2024) & (USD Million)
Table 89. Europe Coagulation Factors Revenue by Country (2025-2031) & (USD Million)
Table 90. Europe Coagulation Factors Sales by Type (2020-2024) & (K Units)
Table 91. Europe Coagulation Factors Sales by Type (2025-2031) & (K Units)
Table 92. Europe Coagulation Factors Sales by Application (2020-2024) & (K Units)
Table 93. Europe Coagulation Factors Sales by Application (2025-2031) & (K Units)
Table 94. Asia-Pacific Coagulation Factors Sales by Region (2020-2024) & (K Units)
Table 95. Asia-Pacific Coagulation Factors Sales by Region (2025-2031) & (K Units)
Table 96. Asia-Pacific Coagulation Factors Revenue by Region (2020-2024) & (USD Million)
Table 97. Asia-Pacific Coagulation Factors Revenue by Region (2025-2031) & (USD Million)
Table 98. Asia-Pacific Coagulation Factors Sales by Type (2020-2024) & (K Units)
Table 99. Asia-Pacific Coagulation Factors Sales by Type (2025-2031) & (K Units)
Table 100. Asia-Pacific Coagulation Factors Sales by Application (2020-2024) & (K Units)
Table 101. Asia-Pacific Coagulation Factors Sales by Application (2025-2031) & (K Units)
Table 102. South America Coagulation Factors Sales by Country (2020-2024) & (K Units)
Table 103. South America Coagulation Factors Sales by Country (2025-2031) & (K Units)
Table 104. South America Coagulation Factors Revenue by Country (2020-2024) & (USD Million)
Table 105. South America Coagulation Factors Revenue by Country (2025-2031) & (USD Million)
Table 106. South America Coagulation Factors Sales by Type (2020-2024) & (K Units)
Table 107. South America Coagulation Factors Sales by Type (2025-2031) & (K Units)
Table 108. South America Coagulation Factors Sales by Application (2020-2024) & (K Units)
Table 109. South America Coagulation Factors Sales by Application (2025-2031) & (K Units)
Table 110. Middle East & Africa Coagulation Factors Sales by Region (2020-2024) & (K Units)
Table 111. Middle East & Africa Coagulation Factors Sales by Region (2025-2031) & (K Units)
Table 112. Middle East & Africa Coagulation Factors Revenue by Region (2020-2024) & (USD Million)
Table 113. Middle East & Africa Coagulation Factors Revenue by Region (2025-2031) & (USD Million)
Table 114. Middle East & Africa Coagulation Factors Sales by Type (2020-2024) & (K Units)
Table 115. Middle East & Africa Coagulation Factors Sales by Type (2025-2031) & (K Units)
Table 116. Middle East & Africa Coagulation Factors Sales by Application (2020-2024) & (K Units)
Table 117. Middle East & Africa Coagulation Factors Sales by Application (2025-2031) & (K Units)
Table 118. Coagulation Factors Raw Material
Table 119. Key Manufacturers of Coagulation Factors Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Coagulation Factors Typical Distributors
Table 123. Coagulation Factors Typical Customers
List of Figures
Figure 1. Coagulation Factors Picture
Figure 2. Global Coagulation Factors Revenue Market Share by Type in 2024
Figure 3. Coagulation Factor VIIa
Figure 4. Coagulation Factor VIII
Figure 5. Coagulation Factor IX
Figure 6. Coagulation Factor X
Figure 7. Other
Figure 8. Global Coagulation Factors Revenue Market Share by Application in 2024
Figure 9. Pharmacy
Figure 10. Hospital
Figure 11. Global Coagulation Factors Revenue, (USD Million) & (K Units): 2020 & 2024 & 2031
Figure 12. Global Coagulation Factors Revenue and Forecast (2020-2031) & (USD Million)
Figure 13. Global Coagulation Factors Sales (2020-2031) & (K Units)
Figure 14. Global Coagulation Factors Price (2020-2031) & (USD/Unit)
Figure 15. Global Coagulation Factors Production Capacity (2020-2031) & (K Units)
Figure 16. Global Coagulation Factors Production Capacity by Geographic Region: 2024 VS 2031
Figure 17. Coagulation Factors Market Drivers
Figure 18. Coagulation Factors Market Restraints
Figure 19. Coagulation Factors Market Trends
Figure 20. Global Coagulation Factors Sales Market Share by Manufacturer in 2024
Figure 21. Global Coagulation Factors Revenue Market Share by Manufacturer in 2024
Figure 22. Coagulation Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 23. Top 3 Coagulation Factors Manufacturer (Revenue) Market Share in 2024
Figure 24. Top 6 Coagulation Factors Manufacturer (Revenue) Market Share in 2024
Figure 25. Global Coagulation Factors Sales Market Share by Region (2020-2031)
Figure 26. Global Coagulation Factors Revenue Market Share by Region (2020-2031)
Figure 27. North America Coagulation Factors Revenue (2020-2031) & (USD Million)
Figure 28. Europe Coagulation Factors Revenue (2020-2031) & (USD Million)
Figure 29. Asia-Pacific Coagulation Factors Revenue (2020-2031) & (USD Million)
Figure 30. South America Coagulation Factors Revenue (2020-2031) & (USD Million)
Figure 31. Middle East & Africa Coagulation Factors Revenue (2020-2031) & (USD Million)
Figure 32. Global Coagulation Factors Sales Market Share by Type (2020-2031)
Figure 33. Global Coagulation Factors Revenue Market Share by Type (2020-2031)
Figure 34. Global Coagulation Factors Price by Type (2020-2031) & (USD/Unit)
Figure 35. Global Coagulation Factors Sales Market Share by Application (2020-2031)
Figure 36. Global Coagulation Factors Revenue Market Share by Application (2020-2031)
Figure 37. Global Coagulation Factors Price by Application (2020-2031) & (USD/Unit)
Figure 38. North America Coagulation Factors Sales Market Share by Type (2020-2031)
Figure 39. North America Coagulation Factors Sales Market Share by Application (2020-2031)
Figure 40. North America Coagulation Factors Sales Market Share by Country (2020-2031)
Figure 41. North America Coagulation Factors Revenue Market Share by Country (2020-2031)
Figure 42. United States Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 43. Canada Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 44. Mexico Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 45. Europe Coagulation Factors Sales Market Share by Type (2020-2031)
Figure 46. Europe Coagulation Factors Sales Market Share by Application (2020-2031)
Figure 47. Europe Coagulation Factors Sales Market Share by Country (2020-2031)
Figure 48. Europe Coagulation Factors Revenue Market Share by Country (2020-2031)
Figure 49. Germany Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 50. France Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 51. United Kingdom Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 52. Russia Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 53. Italy Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 54. Asia-Pacific Coagulation Factors Sales Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Coagulation Factors Sales Market Share by Application (2020-2031)
Figure 56. Asia-Pacific Coagulation Factors Sales Market Share by Region (2020-2031)
Figure 57. Asia-Pacific Coagulation Factors Revenue Market Share by Region (2020-2031)
Figure 58. China Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 59. Japan Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 60. Korea Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 61. India Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 62. Southeast Asia Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 63. Australia Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 64. South America Coagulation Factors Sales Market Share by Type (2020-2031)
Figure 65. South America Coagulation Factors Sales Market Share by Application (2020-2031)
Figure 66. South America Coagulation Factors Sales Market Share by Country (2020-2031)
Figure 67. South America Coagulation Factors Revenue Market Share by Country (2020-2031)
Figure 68. Brazil Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 69. Argentina Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 70. Middle East & Africa Coagulation Factors Sales Market Share by Type (2020-2031)
Figure 71. Middle East & Africa Coagulation Factors Sales Market Share by Application (2020-2031)
Figure 72. Middle East & Africa Coagulation Factors Sales Market Share by Region (2020-2031)
Figure 73. Middle East & Africa Coagulation Factors Revenue Market Share by Region (2020-2031)
Figure 74. Turkey Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 75. Egypt Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 76. Saudi Arabia Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 77. South Africa Coagulation Factors Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Coagulation Factors in 2024
Figure 79. Manufacturing Process Analysis of Coagulation Factors
Figure 80. Coagulation Factors Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

※参考情報

凝固因子とは、血液の凝固過程に関与する一連のタンパク質のことを指します。これらの因子は、血液の流出を防ぎ、傷ついた血管を修復するために不可欠な役割を果たしています。血液が損傷を受けた際、凝固因子が連携して働き、迅速に凝固を促進することで出血を止めるのです。以下に、凝固因子の定義、特徴、種類、用途、関連技術について詳しく説明します。

まず、凝固因子は通常、番号や名称で表されます。一般に、凝固因子はIからXIIIまで番号が付けられており、これに加えて、トロンビンやフィブリノーゲンなど、特定の機能を持つ因子も存在します。このように、凝固因子は厳格なヒエラルキーを有しており、それぞれの因子が特有の役割を果たしています。

凝固因子の特徴として、多くは肝臓で合成される点が挙げられます。特定のビタミンやミネラル（特にビタミンK）が必要であり、これらは凝固因子の機能に欠かせない要素です。凝固因子が正常に機能するためには、これらの栄養素が十分に供給されている必要があります。また、血液中には一定の濃度で存在しており、体内の状態に応じてその活性が調整されます。

凝固因子は主に二つの経路を経て働きます。一つは外因性経路であり、血管外の損傷（例えば、皮膚や粘膜の破損）によって始まります。この経路では、組織因子（TF: Tissue Factor）が重要な役割を果たします。損傷により画一的に被傷部位に露出した組織因子が、凝固因子VIIと結合し、活性化を誘導します。もう一つは内因性経路であり、血管内での血液の流れや内皮細胞の損傷によって誘発されます。

凝固因子の種類については、主に13種類で構成されています。因子I（フィブリノーゲン）は、凝固の最終段階でフィブリンとして変化し、血液の塊を形成します。因子II（プロトロンビン）は、トロンビンに変わり、さらなる凝固因子を活性化します。因子III（トロンボプラスチン）は、外因性経路のスタート地点で重要な役割を果たし、因子VIIを活性化します。因子IV（カルシウムイオン）は、特に各因子の相互作用を促進するために不可欠です。因子Vおよび因子VIIIは、活性化することで他の因子と協働し、凝固を促進します。因子IX（クリスマス因子）や因子Xは、それぞれ内因性および外因性経路の中で重要な役割を果たします。

用途については、凝固因子は主に医療の分野で重要な役割を果たしています。特に、血友病と呼ばれる遺伝性の凝固因子欠乏症においては、特定の因子（例えば、因子VIIIやIX）の補充療法が行われます。これにより、患者の出血を防ぎ、生活の質を向上させることができます。また、手術や外傷時の出血管理のためにも、凝固因子の補充が行われることがあります。

さらに、凝固因子は新しい治療法や診断法の発展にも寄与しています。例えば、血栓症のリスクを減少させる抗凝固薬の開発においても、凝固因子のメカニズムが重要な研究テーマとなっています。抗凝固薬により、血液の凝固機能を制御することで、心血管疾患や脳卒中の予防につなげることが期待されています。

最近の研究では、遺伝子治療の活用も進んでいます。特に血友病に関しては、遺伝子改変を通じて欠乏している凝固因子を生成する能力を持たせる試みが行われています。これにより、定期的な因子補充が不要になり、より持続的な効果が期待されています。

このように、凝固因子は血液凝固という生理学的な過程において中心的な役割を果たしている重要なタンパク質群であり、そのメカニズムの研究は様々な医療分野での応用が進められています。安全で効果的な治療法の確立や進化した医療技術の発展に寄与することが期待されています。凝固因子の正しい理解と、その活用が今後の医療の質の向上に繋がる日が来ることを願っています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 凝固因子VIIaの世界市場2025年：ノボセブン、ノボセブンRT
  • ベスポンサの世界市場2025年：0.9mg、1.0mg
  • ライダプトの世界市場2025年：AML、ASM、SM-AHN、MCL
  • パシレオチドの世界市場2025年：0.3mg/ml、0.6mg/ml、0.9mg/ml
  • ミドスタウリンの世界市場2025年：AML、MDS、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3777 )"凝固因子の世界市場2025年：凝固因子VIIa、凝固因子VIII、凝固因子IX、凝固因子X、その他" (英文：Global Coagulation Factors Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。